The EUR 90m syndicated facility includes amendment and increase of its existing facilities by EUR 24m, which will be used in the acquisition program, both at national and international level.

MedLife published a document on the Bucharest Stock Exchange stating that the company has successfully signed a EUR 90m syndicated facility, which includes amendment and increase of its existing facilities by EUR 24m. The mentioned funds will be used in the acquisition program, both at national and international level.

The syndicate of banks that signed the new syndicated loan is comprising the following lenders: Banca Comercială Română, as coordinator, mandated lead arranger, documentation agent, facility & security agent and lender, BRD Groupe Société Générale, Banca Transilvania and Raiffeisen Bank, as lead arrangers and lenders.

According to the representatives of the group, to this increase in limit may be added own funds of the company, up to a total value of EUR 30m.

As a reminder, MedLife has earlier this month announced the acquisition of the majority stake in Onco Team Diagnostic laboratory, through which the MedLife reached a portfolio of 24 acquired companies.